Exhaled nitric oxide and pulmonary response to iloprost in systemic sclerosis (multiple letters) [4]

Lancet

Volumn 352, Issue 9125, 1998, Pages 405-406

  Marczin, N ^a   Riedel, B ^a   Royston, D ^a   Yacoub, M ^a   Rolla, G ^a  

^a HAREFIELD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCERYL TRINITRATE; ILOPROST; NITRIC OXIDE;

ARTIFICIAL VENTILATION; CAPILLARY FLOW; DRUG METABOLISM; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LETTER; LUNG CIRCULATION; LUNG FUNCTION; METHODOLOGY; OPEN HEART SURGERY; PRIORITY JOURNAL; SYSTEMIC SCLEROSIS;

EID: 0032146927     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)60504-1     Document Type: Letter

References (5)

1. G Rolla P Colagrande L Brussino C Bucca MT Bertero F Caligaris-Cappio Exhaled nitric oxide and pulmonary response to iloprost in systemic sclerosis with pulmonary hypertension Lancet 351 1998 1491 1492
2. M Husain C Adrie F Ichinose M Kavosi WM Zapol Exhaled nitric oxide as a marker for organic nitric tolerance Circulation 89 1994 2498 2502
3. N Marczin B Riedel D Royston M Yacoub Intravenous nitrite vasodilators and exhaled nitric oxide Lancet 349 1997 1742
4. E Dirnberger H Lucan HG Eichler J Kastner T Pernerstorfer B Jilma Effects of nitroglycerin and sodium nitroprusside on endexpiratory concentrations of nitric oxide in healthy humans Life Sci 62 1998 PL103 PL108
5. SA Kharitonov K Alving PJ Barnes Exhaled and nasal nitric oxide measurements: recommendations: The European Respiratory Society Task Force Eur Respir J 7 1997 1683 1693